Format

Send to

Choose Destination
Urol Clin North Am. 2016 May;43(2):195-202. doi: 10.1016/j.ucl.2016.01.006. Epub 2016 Mar 19.

Testosterone and Male Infertility.

Author information

1
Division of Male Reproductive Medicine and Surgery, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
2
Division of Male Reproductive Medicine and Surgery, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: larryl@bcm.edu.

Abstract

Hypogonadism and its therapies have a significant impact on male fertility potential. It is necessary to determine the etiology to treat and counsel the patient appropriately on therapeutic options. For the hypogonadal male on exogenous testosterone, management should begin with cessation of the exogenous testosterone and supplemental subcutaneous human chorionic gonadotropin and an oral follicle-stimulating hormone (FSH)-inducing agent to allow reestablishment of the hypothalamic-pituitary-gonadal axis and spermatogenesis. Further supplemental therapy with recombinant FSH in some patients may be necessary to achieve optimal semen parameters.

KEYWORDS:

Exogenous; Hypogonadism; Hypogonadotropic; Infertility; Spermatogenesis; Testosterone

PMID:
27132576
DOI:
10.1016/j.ucl.2016.01.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center